• Something wrong with this record ?

Expression of Tau Produces Aberrant Plasma Membrane Blebbing in Glial Cells Through RhoA-ROCK-Dependent F-Actin Remodeling

FM. Torres-Cruz, F. Rodríguez-Cruz, J. Escobar-Herrera, N. Barragán-Andrade, G. Basurto-Islas, D. Ripova, J. Ávila, F. Garcia-Sierra,

. 2016 ; 52 (2) : 463-82.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc17014003

Abnormal aggregation of Tau in glial cells has been reported in Alzheimer's disease (AD) and other tauopathies; however, the pathological significance of these aggregates remains unsolved to date. In this study, we evaluated whether full-length Tau (Tau441) and its aspartic acid421-truncated Tau variant (Tau421) produce alterations in the normal organization of the cytoskeleton and plasma membrane (PM) when transiently expressed in cultured C6-glial cells. Forty-eight hours post-transfection, abnormal microtubule bundling was observed in the majority of the cells, which expressed either Tau441 or Tau421. Moreover, both variants of Tau produced extensive PM blebbing associated with cortical redistribution of filamentous actin (F-Actin). These effects were reverted when Tau-expressing cells were incubated with drugs that depolymerize F-Actin. In addition, when glial cells showing Tau-induced PM blebbing were incubated with inhibitors of the Rho-associated protein kinase (ROCK) signaling pathway, both formation of abnormal PM blebs and F-Actin remodeling were avoided. All of these effects were initiated upstream by abnormal Tau-induced microtubule bundling, which may release the microtubule-bound guanine nucleotide exchange factor-H1 (GEF-H1) into the cytoplasm in order to activate its major effector RhoA-GTPase. These results may represent a new mechanism of Tau toxicity in which Tau-induced microtubule bundling produces activation of the Rho-GTPase-ROCK pathway that in turn mediates the remodeling of cortical Actin and PM blebbing. In AD and other tauopathies, these Tau-induced abnormalities may occur and contribute to the impairment of glial activity.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014003
003      
CZ-PrNML
005      
20170426115717.0
007      
ta
008      
170413s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JAD-150396 $2 doi
035    __
$a (PubMed)27003208
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Torres-Cruz, Francisco M $u Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico.
245    10
$a Expression of Tau Produces Aberrant Plasma Membrane Blebbing in Glial Cells Through RhoA-ROCK-Dependent F-Actin Remodeling / $c FM. Torres-Cruz, F. Rodríguez-Cruz, J. Escobar-Herrera, N. Barragán-Andrade, G. Basurto-Islas, D. Ripova, J. Ávila, F. Garcia-Sierra,
520    9_
$a Abnormal aggregation of Tau in glial cells has been reported in Alzheimer's disease (AD) and other tauopathies; however, the pathological significance of these aggregates remains unsolved to date. In this study, we evaluated whether full-length Tau (Tau441) and its aspartic acid421-truncated Tau variant (Tau421) produce alterations in the normal organization of the cytoskeleton and plasma membrane (PM) when transiently expressed in cultured C6-glial cells. Forty-eight hours post-transfection, abnormal microtubule bundling was observed in the majority of the cells, which expressed either Tau441 or Tau421. Moreover, both variants of Tau produced extensive PM blebbing associated with cortical redistribution of filamentous actin (F-Actin). These effects were reverted when Tau-expressing cells were incubated with drugs that depolymerize F-Actin. In addition, when glial cells showing Tau-induced PM blebbing were incubated with inhibitors of the Rho-associated protein kinase (ROCK) signaling pathway, both formation of abnormal PM blebs and F-Actin remodeling were avoided. All of these effects were initiated upstream by abnormal Tau-induced microtubule bundling, which may release the microtubule-bound guanine nucleotide exchange factor-H1 (GEF-H1) into the cytoplasm in order to activate its major effector RhoA-GTPase. These results may represent a new mechanism of Tau toxicity in which Tau-induced microtubule bundling produces activation of the Rho-GTPase-ROCK pathway that in turn mediates the remodeling of cortical Actin and PM blebbing. In AD and other tauopathies, these Tau-induced abnormalities may occur and contribute to the impairment of glial activity.
650    _2
$a aktiny $x účinky léků $x metabolismus $7 D000199
650    _2
$a zvířata $7 D000818
650    _2
$a western blotting $7 D015153
650    _2
$a buněčné linie $7 D002460
650    _2
$a buněčná membrána $x účinky léků $x metabolismus $x patologie $7 D002462
650    _2
$a cytoplazma $x metabolismus $7 D003593
650    _2
$a elektroforéza $7 D004586
650    _2
$a fluorescenční protilátková technika $7 D005455
650    _2
$a zelené fluorescenční proteiny $x genetika $x metabolismus $7 D049452
650    _2
$a výměnné faktory guaninnukleotidů $x metabolismus $7 D020662
650    _2
$a koncové značení zlomů DNA in situ $7 D020287
650    _2
$a konfokální mikroskopie $7 D018613
650    _2
$a neuroglie $x účinky léků $x metabolismus $x patologie $7 D009457
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a transfekce $7 D014162
650    _2
$a tubulin $x metabolismus $7 D014404
650    _2
$a kinázy asociované s rho $x metabolismus $7 D054460
650    _2
$a rhoA protein vázající GTP $x metabolismus $7 D020742
650    _2
$a proteiny tau $x genetika $x metabolismus $7 D016875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rodríguez-Cruz, Fanny $u Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico.
700    1_
$a Escobar-Herrera, Jaime $u Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico.
700    1_
$a Barragán-Andrade, Norma $u Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico.
700    1_
$a Basurto-Islas, Gustavo $u División de Ciencias e Ingenierías, Universidad de Guanajuato, Guanajuato, Mexico.
700    1_
$a Ripova, Daniela $u National Institute of Mental Health, Klecany, Czech Republic.
700    1_
$a Ávila, Jesús $u Centro de Biología Molecular Severo Ochoa (CSIC-UAM) Universidad Autónoma de Madrid, Spain.
700    1_
$a Garcia-Sierra, Francisco $u Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico.
773    0_
$w MED00006350 $t Journal of Alzheimer's disease JAD $x 1875-8908 $g Roč. 52, č. 2 (2016), s. 463-82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27003208 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426120035 $b ABA008
999    __
$a ok $b bmc $g 1200468 $s 974781
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 52 $c 2 $d 463-82 $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Logged in users only

Archiving options